U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
139594
Substance Class Protein
Created
by admin
on Sat Dec 16 17:00:41 GMT 2023
Edited
by admin
on Sat Dec 16 17:00:41 GMT 2023
Protein Type MONOCLONAL ANTIBODY CONJUGATE
Protein Sub Type IGG1
Sequence Origin CHIMERIC/HUMANIZED MOUSE
Sequence Type COMPLETE
Record UNII
F3R7A4P04N
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
DEPATUXIZUMAB MAFODOTIN
INN   USAN   WHO-DD  
INN   USAN  
Official Name English
IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS EGFR (EPIDERMAL GROWTH FACTOR RECEPTOR, RECEPTOR TYROSINE-PROTEIN KINASE ERBB-1, ERBB1, HER1, HER-1, ERBB)), HUMANIZED AND CHIMERIC MONOCLONAL ANTIBODY CONJUGATED TO AURISTATIN F
Systematic Name English
IMMUNOGLOBULIN G1, ANTI-(HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR) (HUMAN-MUS MUSCULUS MONOCLONAL ABT-806 HEAVY CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL ABT-806 LIGHT CHAIN, DIMER, TETRAKIS(THIOETHER) WITH N-(6-(3-MERCAPTO-2,5-DIOXO-1-PYRROLIDI
Systematic Name English
DEPATUXIZUMAB MAFODOTIN [JAN]
Common Name English
Depatuxizumab mafodotin [WHO-DD]
Common Name English
depatuxizumab mafodotin [INN]
Common Name English
ABT-414
Code English
DEPATUXIZUMAB MAFODOTIN [USAN]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C129825
Created by admin on Sat Dec 16 17:00:43 GMT 2023 , Edited by admin on Sat Dec 16 17:00:43 GMT 2023
FDA ORPHAN DRUG 433214
Created by admin on Sat Dec 16 17:00:43 GMT 2023 , Edited by admin on Sat Dec 16 17:00:43 GMT 2023
NCI_THESAURUS C2167
Created by admin on Sat Dec 16 17:00:43 GMT 2023 , Edited by admin on Sat Dec 16 17:00:43 GMT 2023
Code System Code Type Description
WIKIPEDIA
DEPATUXIZUMAB MAFODOTIN
Created by admin on Sat Dec 16 17:00:43 GMT 2023 , Edited by admin on Sat Dec 16 17:00:43 GMT 2023
PRIMARY
NCI_THESAURUS
C105612
Created by admin on Sat Dec 16 17:00:43 GMT 2023 , Edited by admin on Sat Dec 16 17:00:43 GMT 2023
PRIMARY
ChEMBL
CHEMBL3707277
Created by admin on Sat Dec 16 17:00:43 GMT 2023 , Edited by admin on Sat Dec 16 17:00:43 GMT 2023
PRIMARY
CAS
1585973-65-4
Created by admin on Sat Dec 16 17:00:43 GMT 2023 , Edited by admin on Sat Dec 16 17:00:43 GMT 2023
PRIMARY
USAN
CD-14
Created by admin on Sat Dec 16 17:00:43 GMT 2023 , Edited by admin on Sat Dec 16 17:00:43 GMT 2023
PRIMARY
FDA UNII
F3R7A4P04N
Created by admin on Sat Dec 16 17:00:43 GMT 2023 , Edited by admin on Sat Dec 16 17:00:43 GMT 2023
PRIMARY
DRUG BANK
DB11731
Created by admin on Sat Dec 16 17:00:43 GMT 2023 , Edited by admin on Sat Dec 16 17:00:43 GMT 2023
PRIMARY
INN
10263
Created by admin on Sat Dec 16 17:00:43 GMT 2023 , Edited by admin on Sat Dec 16 17:00:43 GMT 2023
PRIMARY
EVMPD
SUB181033
Created by admin on Sat Dec 16 17:00:43 GMT 2023 , Edited by admin on Sat Dec 16 17:00:43 GMT 2023
PRIMARY
From To
1_22 1_96
1_143 1_199
1_219 3_214
1_225 2_225
1_228 2_228
1_260 1_320
1_366 1_424
2_22 2_96
2_143 2_199
2_219 4_214
2_260 2_320
2_366 2_424
3_23 3_88
3_134 3_194
4_23 4_88
4_134 4_194
Glycosylation Type MAMMALIAN
Glycosylation Link Type Site
N 1_296
N 2_296
Related Record Type Details
Structure of MAFODOTIN
CONJUGATE COMPONENT->CONJUGATE
EPIDERMAL GROWTH FACTOR RECEPTOR
TARGET->LIGAND
DEPATUXIZUMAB
CONJUGATE COMPONENT->CONJUGATE
EPIDERMAL GROWTH FACTOR RECEPTOR
TARGET -> INHIBITOR
Related Record Type Details
DEPATUXIZUMAB MAFODOTIN
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
MOL_WEIGHT:CALCULATED CHEMICAL
Molecular Formula CHEMICAL
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966